# A Study of TAK-079 in People With Generalized Myasthenia Gravis

> **NCT04159805** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 36 (actual)

## Conditions studied

- Myasthenia Gravis

## Interventions

- **DRUG:** TAK-079
- **DRUG:** TAK-079 Placebo

## Key facts

- **NCT ID:** NCT04159805
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-14
- **Primary completion:** 2022-07-12
- **Final completion:** 2022-07-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04159805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04159805, "A Study of TAK-079 in People With Generalized Myasthenia Gravis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04159805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*